Investigation of the degradation and in-situ amorphization of the enantiomeric drug escitalopram oxalate during Fused Deposition Modeling (FDM) 3D printing

Paliperidone palmitate as model of heat-sensitive drug for long-acting 3D printing application

(2022) Giuseppe Manini et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Solid Dispersion Formulations by FDM 3D Printing—A Review

(2022) Garba M. Khalid et al.   Pharmaceutics

3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy

(2022) Hellen Windolf et al.   Pharmaceutics

Development of a multiparticulate drug delivery system for in situ amorphisation

(2022) Tobias Palle Holm et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

3D printed oral solid dosage form: Modified release and improved solubility

(2022) Ning Wang et al.   JOURNAL OF CONTROLLED RELEASE

Hot-Melt Extrusion of the Thermo-Sensitive Peptidomimetic Drug Enalapril Maleate

(2022) Lena Hoffmann et al.   Pharmaceutics

Fused Deposition Modeling (FDM) 3D Printing of the Thermo-Sensitive Peptidomimetic Drug Enalapril Maleate

(2022) Lena Hoffmann et al.   Pharmaceutics

3D Printing of Mini Tablets for Pediatric Use

(2021) Julius Krause et al.   Pharmaceuticals

Investigation on the Solubility of the Antidepressant Drug Escitalopram in Subcritical Water

(2021) Sema Akay et al.   JOURNAL OF CHEMICAL AND ENGINEERING DATA

Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug–Polymer Interactions

(2021) Tze Ning Hiew et al.   MOLECULAR PHARMACEUTICS

Fabrication and Characterization of Fast-Dissolving Films Containing Escitalopram/Quetiapine for the Treatment of Major Depressive Disorder

(2021) Manal E. Alkahtani et al.   Pharmaceutics

3D Printing of Thermo-Sensitive Drugs

(2021) Sadikalmahdi Abdella et al.   Pharmaceutics

Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic

(2021) Damian F Santomauro et al.   LANCET

Oral Fixed-Dose Combination Pharmaceutical Products: Industrial Manufacturing Versus Personalized 3D Printing

(2020) Raquel Fernández-García et al.   PHARMACEUTICAL RESEARCH

The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations–printability–process modulation, with consecutive effects on in vitro release, stability and degradation

(2019) Kinga Ilyés et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Reshaping drug development using 3D printing

(2018) Atheer Awad et al.   DRUG DISCOVERY TODAY

Development of a dual extrusion printing technique for an acid- and thermo-labile drug

(2018) Wiebke Kempin et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs

(2018) Gayathri Kollamaram et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Thermal degradation mechanism for citalopram and escitalopram

(2018) B. V. Pinto et al.   JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY

3D Printed “Starmix” Drug Loaded Dosage Forms for Paediatric Applications

(2018) Nicolaos Scoutaris et al.   PHARMACEUTICAL RESEARCH

A critical review on 3D-printed dosage forms

(2018) Ilias El Aita et al.   CURRENT PHARMACEUTICAL DESIGN

Patient acceptability of 3D printed medicines

(2017) Alvaro Goyanes et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Amorphization within the tablet: Using microwave irradiation to form a glass solution in situ

(2017) Maria Doreth et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Regulating the Skin Permeation Rate of Escitalopram by Ion-pair Formation with Organic Acids

(2016) Tian Song et al.   AAPS PHARMSCITECH

Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: A QbD approach

(2016) Jaywant Pawar et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Emergence of 3D Printed Dosage Forms: Opportunities and Challenges

(2016) Mohamed A. Alhnan et al.   PHARMACEUTICAL RESEARCH

3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets

(2015) Alvaro Goyanes et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Amorphous formulations for dissolution and bioavailability enhancement of poorly soluble APIs

(2015) P. Kanaujia et al.   POWDER TECHNOLOGY

Insoluble drug delivery strategies: review of recent advances and business prospects

(2015) Sandeep Kalepu et al.   Acta Pharmaceutica Sinica B

Amorphous drugs and dosage forms

(2015) H. Grohganz et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Dielectric spectroscopy for the determination of the glass transition temperature of pharmaceutical solid dispersions

(2014) Kevin P. O’Donnell et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder

(2013) Gerald Gartlehner et al.   ANNALS OF INTERNAL MEDICINE

Preparation and Properties of Electrospun Soy Protein Isolate/Polyethylene Oxide Nanofiber Membranes

(2012) Xuezhu Xu et al.   ACS Applied Materials & Interfaces

Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability

(2012) Eiji Kirino   Patient Preference and Adherence

Formation of solid solutions between racemic and enantiomeric citalopram oxalate

(2011) Heidi Lopez de Diego et al.   CHIRALITY

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

(2009) Andrea Cipriani et al.   LANCET

Isolation and characterization of degradation products of citalopram and process-related impurities using RP-HPLC

(2008) Ramisetti Nageswara Rao et al.   JOURNAL OF SEPARATION SCIENCE